Lund, Sweden, 8:00 CET, January 4 2019 – BONESUPPORT™ an emerging leader in Orthobiologics for the management of bone voids, announces changes in its leadership team that will take place March 1, 2019. Annelie Aava Vikner starts in a new position as the company´s Executive Vice President Global Marketing & Communications. Annelie Aava Vikner has more than 15 years of experience from various marketing management positions at Medtronic, the USA founded healthcare technology company. Most recently she functioned as Senior Strategy & Marketing Manager Austria, Switzerland, Benelux, Greece, Israel & Nordic.
“Annelie Aava Vikner will be an important addition to the BONESUPPORT leadership team. Her experience will be of value for the exciting time ahead of us. Additionally, I want to thank Linda Butcher for her achievements as Chief Marketing Officer. Linda takes on the role as Vice President of Training & Events” says Emil Billbäck, BONESUPPORT CEO.
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. The company is based in Lund, Sweden, and the net sales amounted to SEK 129 million in 2017. Please visit www.bonesupport.com for more information.
BONESUPPORT® and CERAMENT® are registered trademarks
For more information contact:
Emil Billbäck, CEO
+46 (0) 46 286 53 70
Håkan Johansson, CFO
+46(0) 46 286 53 70
Citigate Dewe Rogerson
Pip Batty, David Dible, Shabnam Bashir
+44 (0)20 7638 9571
This information is such information as BONESUPPORT HOLDING AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8.00 CET on 4 January 2019.